U.S. markets close in 1 hour 19 minutes
  • S&P 500

    4,389.95
    -20.18 (-0.46%)
     
  • Dow 30

    34,423.70
    +59.20 (+0.17%)
     
  • Nasdaq

    13,707.39
    -147.74 (-1.07%)
     
  • Russell 2000

    2,016.55
    -16.97 (-0.83%)
     
  • Crude Oil

    85.61
    +2.30 (+2.76%)
     
  • Gold

    1,852.30
    +10.60 (+0.58%)
     
  • Silver

    23.99
    +0.19 (+0.80%)
     
  • EUR/USD

    1.1301
    -0.0029 (-0.26%)
     
  • 10-Yr Bond

    1.7810
    +0.0460 (+2.65%)
     
  • GBP/USD

    1.3513
    +0.0023 (+0.17%)
     
  • USD/JPY

    113.9350
    -0.0250 (-0.02%)
     
  • BTC-USD

    37,053.34
    +1,244.38 (+3.48%)
     
  • CMC Crypto 200

    844.83
    +24.25 (+2.95%)
     
  • FTSE 100

    7,371.46
    +74.31 (+1.02%)
     
  • Nikkei 225

    27,131.34
    -457.03 (-1.66%)
     

Treace Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • TMCI

PONTE VEDRA, Fla., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ procedure, today announced that John T. Treace, Chief Executive Officer, and Mark Hair, Chief Financial Officer, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021, beginning at approximately 4:15 pm ET.

A live webcast and replay of the fireside chat will be available on the Company’s investors relations website at https://investors.treace.com/.

About Treace Medical Concepts
Treace Medical Concepts, Inc. is a commercial-stage orthopaedic medical device company with the goal of advancing the standard of care for the surgical management of bunion deformities. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot. Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system - a combination of instruments, implants, and surgical methods designed to correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and getting patients back to their active lives quickly.

Contacts:
Treace Medical Concepts
Mark L. Hair
Chief Financial Officer
mhair@treace.net
(904) 373-5940

Investors:
Gilmartin Group
Lynn Lewis or Vivian Cervantes
IR@treace.net